The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product
The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product
美國食品和藥物管理局針對Mimedx的指定申請發佈了裁決書,指出Axiofill不符合人體細胞、組織或細胞或組織類產品的監管分類要求
The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product
美國食品和藥物管理局針對Mimedx的指定申請發佈了裁決書,指出Axiofill不符合人體細胞、組織或細胞或組織類產品的監管分類要求